ARE POSTSYNAPTIC 5-HT1A RECEPTORS INVOLVED IN THE ANXIOLYTIC EFFECTS OF 5-HT1A RECEPTOR AGONISTS AND IN THEIR INHIBITORY EFFECTS ON THE FIRING OF SEROTONERGIC NEURONS IN THE RAT

被引:0
|
作者
JOLAS, T
SCHREIBER, R
LAPORTE, AM
CHASTANET, M
DEVRY, J
GLASER, T
ADRIEN, J
HAMON, M
机构
[1] UNIV PARIS 06,INSERM,U288,F-75634 PARIS 13,FRANCE
[2] TROPONWERKE GMBH & CO KG,INST NEUROBIOL,DEPT PSYCHOPHARMACOL,D-51063 COLOGNE,GERMANY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous studies have shown that injection of 5-hydroxytryptamine (serotonin) receptor agonists in the dorsal raphe nucleus (DRN) to stimulate somatodendritic 5-HT1A autoreceptors or in the hippocampus to stimulate postsynaptic 5-HT1A receptors, induces anxiolytic-like effects in the rat. The mechanisms triggered by the latter treatment were investigated by measuring both the electrical activity of serotonergic DRN neurons and the anxiolytic response in rats receiving injections with 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) or ipsapirone into the dorsal hippocampus. Anxiety-related behavior was estimated by recording the time of ultrasonic vocalization (USV) due to electric foot shocks under standardized conditions. Intrahippocampal application of 8-OH-DPAT or ipsapirone produced a dose-dependent inhibition of the firing of serotonergic DRN neurons and of the shock-induced USV response. However, the range of efficient doses of 8-OH-DPAT via the intrahippocampal route (1-10 mu g/rat) was larger than that using the i.v. route of injection (0.15-2.5 mu g/rat). Furthermore, maximal inhibition of the firing of DRN serotonergic neurons occurred earlier when 8-OH-DPAT was injected i.v. (within 1-2 min) than when it was injected into the dorsal hippocampus (within 5 min). Interestingly, the injection of 8-OH-DPAT into the striatum, where 5-HT1A receptors are hardly detectable, or a lateral ventricle, also yielded dose-dependent reduction in both the firing rate of serotonergic DRN neurons and the USV response. Finally, local lesion with ibotenic acid to eliminate postsynaptic 5-HT1A receptors did not alter the inhibitory effects of intrahippocampal application of 8-OH-DPAT on the firing of serotonergic DRN neurons and the USV response. These data indicated that postsynaptic 5-HT1A receptors were not responsible for the inhibitory effects of 8-OH-DPAT and ipsapirone injected in forebrain areas on the electrical activity of serotonergic neurons and the USV response in rats. As shown by the autoradiographic labeling by [H-3]8-OH-DPAT at distance from its injection site in the dorsal hippocampus, the diffusion of 5-HT1A receptor agonists (from injected areas in the forebrain to the DRN where they directly inhibit the electrical activity of serotonergic neurons) more likely accounted for their anxiolytic-like effects.
引用
收藏
页码:920 / 929
页数:10
相关论文
共 50 条
  • [1] EFFECTS OF NOVEL 5-HT1A RECEPTOR ANTAGONISTS ON MEASURES OF POSTSYNAPTIC 5-HT1A RECEPTOR ACTIVATION IN-VIVO
    THIELEN, RJ
    FRAZER, A
    [J]. LIFE SCIENCES, 1995, 56 (07) : PL163 - PL168
  • [2] Anxiolytic effects of prelimbic 5-HT1A receptor activation in the hemiparkinsonian rat
    Hui, Yan Ping
    Wang, Tao
    Han, Ling Na
    Li, Li Bo
    Sun, Yi Na
    Liu, Jian
    Qiao, Hong Fei
    Zhang, Qiao Jun
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2015, 277 : 211 - 220
  • [3] The 5-HT1A paradox:: Why 5-HT inhibits and 5-HT1A agonists activate pyramidal neurons in prefrontal cortex through 5-HT1A receptors?
    Llado-Pelfort, L.
    Newman-Tancredi, A.
    Perez, F. Artigas
    Pedrosa, P. Celada
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 112 - 112
  • [4] NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS
    MILLAN, MJ
    CANTON, H
    GOBERT, A
    LEJEUNE, F
    RIVET, JM
    BERVOETS, K
    BROCCO, M
    WIDDOWSON, P
    MENNINI, T
    AUDINOT, V
    HONORE, P
    RENOUARD, A
    LEMAROUILLEGIRARDON, S
    VERRIELE, L
    GRESSIER, H
    PEGLION, JL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (01): : 337 - 352
  • [5] In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
    Llado-Pelfort, Laia
    Assie, Marie-Bernadette
    Newman-Tancredi, Adrian
    Artigas, Francesc
    Celada, Pau
    [J]. PSYCHOPHARMACOLOGY, 2012, 221 (02) : 261 - 272
  • [6] In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
    Laia Lladó-Pelfort
    Marie-Bernadette Assié
    Adrian Newman-Tancredi
    Francesc Artigas
    Pau Celada
    [J]. Psychopharmacology, 2012, 221 : 261 - 272
  • [7] Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus:: lack of interaction with imipramine
    Gur, E
    Lifschytz, T
    Van de Kar, LD
    Lerer, B
    Newman, ME
    [J]. PSYCHONEUROENDOCRINOLOGY, 2004, 29 (09) : 1172 - 1183
  • [8] NORADRENALINE-SEROTONIN INTERACTIONS IN THE ANXIOLYTIC EFFECTS OF 5-HT1A AGONISTS
    LOPEZRUBALCAVA, C
    FERNANDEZGUASTI, A
    [J]. BEHAVIOURAL PHARMACOLOGY, 1994, 5 (01): : 42 - 51
  • [9] The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response
    R. J. E. Joordens
    T. H. Hijzen
    B. Olivier
    [J]. Psychopharmacology, 1998, 139 : 383 - 390
  • [10] The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response
    Joordens, RJE
    Hijzen, TH
    Olivier, B
    [J]. PSYCHOPHARMACOLOGY, 1998, 139 (04) : 383 - 390